National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1380221

Government Disclaimer on use of this data



Case Details

VAERS ID: 1380221 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-20
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-06-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure decreased, Blood pressure measurement, Dyspnoea, Headache
SMQs:, Anaphylactic reaction (narrow), Neuroleptic malignant syndrome (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: LASITONE; COAPROVEL; PLAVIX; LACIREX; PANTORC; NITROGLICERIN DOC GENERICI
Current Illness: Angina unstable (In drug therapy); Atrial fibrillation (In drug therapy); Cardiac failure acute (In drug therapy); Hypertension arterial (In drug therapy)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210508; Test Name: Blood pressure drop arterial; Result Unstructured Data: Test Result:unknown result; Test Date: 20210508; Test Name: blood pressure; Result Unstructured Data: Test Result:50/73 mmHg
CDC Split Type: ITPFIZER INC2021632881

Write-up: Breathing difficult; Ice pick headache; This a spontaneous report received from a contactable consumer (patient''s daughter). This is the 2nd of 2 reports. The 1st report was downloaded from the Regulatory Authority (RA)-WEB [Regulatory Authority report number IT-MINISAL02-734538]. A 95-year-old female patient received the 1st dose of bnt162b2 (COMIRNATY), intramuscular, on 20Mar2021, as single dose, for COVID-19 immunisation. Medical history included ongoing atrial fibrillation (in drug therapy), ongoing cardiac failure (in drug therapy), ongoing hypertension (in drug therapy), ongoing angina unstable (in drug therapy). Patient was in good general health. Concomitant medications included furosemide, spironolactone (LASITONE) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide, irbesartan (COAPROVEL) taken for an unspecified indication, start and stop date were not reported; clopidogrel bisulfate (PLAVIX) taken for an unspecified indication, start and stop date were not reported; lacidipine (LACIREX) taken for an unspecified indication, start and stop date were not reported; pantoprazole sodium sesquihydrate (PANTORC) taken for an unspecified indication, start and stop date were not reported; glyceryl trinitrate (NITROGLICERIN DOC GENERICI) taken for an unspecified indication, start and stop date were not reported. The patient experienced breathing difficult (death, caused hospitalization) on 2021, ice pick headache (death, caused hospitalization) on 2021. The patient was hospitalized die to the events in Mar2021 for 2 days. The patient underwent lab tests and procedures which included blood pressure decreased: unknown result on 08May2021, blood pressure measurement: 50/73 mmhg on 08May2021. The patient died on 10May2021. It was not reported if an autopsy was performed. Clinical course: In the following days she becomes unwell with episodes of headache and breathing difficulties. She goes to the emergency room of the hospital where she is discharged with the suggestion to carry out a cardiological examination; around 06Apr2021 the patient again reported headache and breathing difficulties. She is therefore taken to the hospital where, following a cardiological visit, she has been hospitalized for a few days, skipping the date of the second dose scheduled for 10Apr2021. She was discharged in clinical conditions in general improvement and on 28Apr2021, on the advice of the doctors, she received the second dose of the vaccine at home. On 08May2021 the symptoms manifested following the 1st dose reappeared in a much more intense and acute way, with excruciating headache and difficulty in breathing but also chest pain, lowering of arterial P (minimum value detected: 50 / 73 mmHg) and aphasia. She was hospitalized again, after 2 days the death was noted. Pressure value found at the first measurement after the onset of discomfort: 50/73 mmHg. Reporter''s comment: The administration of both doses of the vaccine was carried out at home by different operators. The batch or expiry date is not indicated on the vaccination sheet issued only for the second dose. The cardiologist who followed the patient recommended taking the second dose despite the symptoms that had already occurred following the first. After the access to the emergency room around 24Mar2021 (after the 1st dose) she was discharged shortly after without any therapy; for the 2 days of hospitalization. Sender''s comment: 21May2021: lots and expirations of both doses of vaccine administered are requested from the reporter; 24May2021: information on the patient''s clinical status and drug therapy is requested from the GP, who confirms the monthly prescribed therapies as reported and reports that he has never visited the patient lately, being treated by a cardiologist specialist. No follow-up attempts are possible; information about lot/batch number cannot be obtained.Information on lot and batch numbers cannot be obtained.; Reporter''s Comments: After the access to the emergency room around 24Mar2021 (after the 1st dose) she was discharged shortly after without any therapy; for the 2 days of hospitalization.; Sender''s Comments: Linked Report(s) : IT-PFIZER INC-2021628330 Same patient/drug, different events; Reported Cause(s) of Death: Breathing difficult; Ice pick headache


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1380221


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166